NEUBASE THERAPEUTICS INC - COM (NBSE)

CUSIP: 64132K102

Q3 2019 13F Holders as of 30 Sep 2019

Type / Class
Equity / COM
Total 13F shares
1,927,245
Share change
+1,927,245
Total reported value
$9,616,000
Price per share
$4.99
Number of holders
14
Value change
+$9,616,000
Number of buys
14

Quarterly Holders Quick Answers

What is CUSIP 64132K102?
CUSIP 64132K102 identifies NBSE - NEUBASE THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of NEUBASE THERAPEUTICS INC - COM (NBSE) as of Q3 2019

As of 30 Sep 2019, NEUBASE THERAPEUTICS INC - COM (NBSE) was held by 14 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,927,245 shares. The largest 10 holders included GREENLIGHT CAPITAL INC, RENAISSANCE TECHNOLOGIES LLC, VANGUARD GROUP INC, BlackRock Inc., FNY Investment Advisers, LLC, GEODE CAPITAL MANAGEMENT, LLC, Virtu Financial LLC, Heritage Wealth Advisors, MORGAN STANLEY, and UBS Group AG. This page lists 14 institutional shareholders reporting positions in this security for the Q3 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.